CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 85 enrolled
Drug / intervention
Fluzone High Dose Vaccine +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01205581
NCT01205581Phase 2Completed
CompareCT.gov

Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV

St. Jude Children's Research Hospital·interventional·Posted Sep 20, 2010·Updated Sep 23, 2016

In Brief

A Phase 2 clinical trial evaluating Fluzone High Dose Vaccine and Fluzone Standard Dose Vaccine for HIV and Cancer. Completed, enrolled 85 participants across 1 site.

Detailed Summary

This is an open label-study of Fluzone HD, a high-dose form of trivalent, inactivated influenza vaccine (TIV), vs. Fluzone, a standard-dose form of TIV. Subjects with cancer or HIV will be vaccinated twice with one of the two vaccines and evaluated for development of immune responses.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHIV, Cancer
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 20, 2010
Enrollment StartSep 1, 2010
Primary CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 15.8 years ago

Interventions

Fluzone High Dose Vaccinebiological

Two doses of Fluzone HD will be administered to children with leukemia, solid tumor, or HIV.

Fluzone Standard Dose Vaccinebiological

Two doses of Fluzone Standard Dose Vaccine will be administered to children with leukemia, solid tumor, or HIV.